These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

334 related articles for article (PubMed ID: 35320699)

  • 1. Nanotherapeutics and the Brain.
    Joseph A; Nance E
    Annu Rev Chem Biomol Eng; 2022 Jun; 13():325-346. PubMed ID: 35320699
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nanomedicine based strategies for oligonucleotide traversion across the blood-brain barrier.
    Amulya E; Sikder A; Vambhurkar G; Shah S; Khatri DK; Raghuvanshi RS; Singh SB; Srivastava S
    J Control Release; 2023 Feb; 354():554-571. PubMed ID: 36649742
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nanotherapeutics for Alzheimer's Disease with Preclinical Evaluation and Clinical Trials: Challenges, Promises and Limitations.
    Bukhari SNA
    Curr Drug Deliv; 2022; 19(1):17-31. PubMed ID: 34514990
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overcoming the Blood-Brain Barrier: The Role of Nanomaterials in Treating Neurological Diseases.
    Furtado D; Björnmalm M; Ayton S; Bush AI; Kempe K; Caruso F
    Adv Mater; 2018 Nov; 30(46):e1801362. PubMed ID: 30066406
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nanotherapeutics: An insight into healthcare and multi-dimensional applications in medical sector of the modern world.
    Prasad M; Lambe UP; Brar B; Shah I; J M; Ranjan K; Rao R; Kumar S; Mahant S; Khurana SK; Iqbal HMN; Dhama K; Misri J; Prasad G
    Biomed Pharmacother; 2018 Jan; 97():1521-1537. PubMed ID: 29793315
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nanoparticle-Based Technology Approaches to the Management of Neurological Disorders.
    Sim TM; Tarini D; Dheen ST; Bay BH; Srinivasan DK
    Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32842530
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nanoparticle Drug Delivery Can Reduce the Hepatotoxicity of Therapeutic Cargo.
    Yang F; Medik Y; Li L; Tian X; Fu D; Brouwer KLR; Wagner K; Sun B; Sendi H; Mi Y; Wang AZ
    Small; 2020 Feb; 16(7):e1906360. PubMed ID: 31972070
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nanotherapeutics in the EU: an overview on current state and future directions.
    Hafner A; Lovrić J; Lakoš GP; Pepić I
    Int J Nanomedicine; 2014; 9():1005-23. PubMed ID: 24600222
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeted nanoparticles for image-guided treatment of triple-negative breast cancer: clinical significance and technological advances.
    Miller-Kleinhenz JM; Bozeman EN; Yang L
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2015; 7(6):797-816. PubMed ID: 25966677
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Emerging Use of Nanotechnology in the Treatment of Neurological Disorders.
    Chhabra R; Tosi G; Grabrucker AM
    Curr Pharm Des; 2015; 21(22):3111-30. PubMed ID: 26027574
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nanotherapeutics Engineered to Cross the Blood-Brain Barrier for Advanced Drug Delivery to the Central Nervous System.
    Kim J; Ahn SI; Kim Y
    J Ind Eng Chem; 2019 May; 73():8-18. PubMed ID: 31588177
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Linkers: The key elements for the creation of efficient nanotherapeutics.
    Hassanzadeh P; Atyabi F; Dinarvand R
    J Control Release; 2018 Jan; 270():260-267. PubMed ID: 29246786
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nanotechnology-based drug delivery for central nervous system disorders.
    Nguyen TT; Dung Nguyen TT; Vo TK; Tran NM; Nguyen MK; Van Vo T; Van Vo G
    Biomed Pharmacother; 2021 Nov; 143():112117. PubMed ID: 34479020
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Review of the Common Neurodegenerative Disorders: Current Therapeutic Approaches and the Potential Role of Nanotherapeutics.
    Lamptey RNL; Chaulagain B; Trivedi R; Gothwal A; Layek B; Singh J
    Int J Mol Sci; 2022 Feb; 23(3):. PubMed ID: 35163773
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Applying nanotherapeutics to improve chemoradiotherapy treatment for cancer.
    Caster JM; Wang AZ
    Ther Deliv; 2017 Aug; 8(9):791-803. PubMed ID: 28825397
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A brief glimpse over the horizon for type 1 diabetes nanotherapeutics.
    Garciafigueroa Y; Trucco M; Giannoukakis N
    Clin Immunol; 2015 Sep; 160(1):36-45. PubMed ID: 25817545
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nanotheranostics, a future remedy of neurological disorders.
    Sharma M; Dube T; Chibh S; Kour A; Mishra J; Panda JJ
    Expert Opin Drug Deliv; 2019 Feb; 16(2):113-128. PubMed ID: 30572726
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Grand challenges in nanomedicine.
    Wu LP; Wang D; Li Z
    Mater Sci Eng C Mater Biol Appl; 2020 Jan; 106():110302. PubMed ID: 31753337
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neutrophil-mediated delivery of nanotherapeutics across blood vessel barrier.
    Dong X; Chu D; Wang Z
    Ther Deliv; 2018 Jan; 9(1):29-35. PubMed ID: 29216803
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anticancer Nanotherapeutics in Clinical Trials: The Work behind Clinical Translation of Nanomedicine.
    Parodi A; Kolesova EP; Voronina MV; Frolova AS; Kostyushev D; Trushina DB; Akasov R; Pallaeva T; Zamyatnin AA
    Int J Mol Sci; 2022 Nov; 23(21):. PubMed ID: 36362156
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.